ClinConnect ClinConnect Logo
Search / Trial NCT06831110

Aquagenic Wrinkling Prediction

Launched by UNIVERSITY OF IOWA · Feb 13, 2025

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial, titled "Aquagenic Wrinkling Prediction," is looking to see if soaking hands in water for up to 20 minutes can help identify people who are carriers of cystic fibrosis (CF), a genetic condition. The study is observational, which means it will simply observe how participants' hands respond to the water soaking procedure without any treatment involved.

To participate, individuals must be between the ages of 65 and 75 and should be interested in other research related to cystic fibrosis carriers. However, those who are currently diagnosed with cystic fibrosis, unable to speak English, or have certain medical conditions like diabetes or skin issues are not eligible. During the study, participants will attend one visit where they will undergo the hand soaking procedure and see how their skin reacts. It's a straightforward process designed to help researchers learn more about this condition and improve screening methods in the future.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Interested in participating in other CF Carrier-related research studies.
  • Exclusion Criteria:
  • CF patient status
  • Unable to speak English
  • Unable to provide written informed consent
  • Prisoner status
  • An open wound on either hand
  • A tattoo on either hand
  • Missing any portion of either hand
  • Diagnosis of Diabetes
  • Diagnosis of Hyperhidrosis
  • Diagnosis of Raynaud's Disease
  • Diagnosis of Atopic Dermatitis
  • Regularly taking ACE inhibitors or angiotensin receptor blockers

About University Of Iowa

The University of Iowa, a leading academic and research institution, is dedicated to advancing healthcare through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the university harnesses the expertise of its faculty and researchers to investigate cutting-edge therapies and treatments across various medical fields. Committed to ethical research practices and patient-centered care, the University of Iowa strives to contribute significantly to medical knowledge and improve health outcomes through rigorous scientific inquiry and community engagement.

Locations

Iowa City, Iowa, United States

Patients applied

0 patients applied

Trial Officials

Philip M Polgreen, MD

Principal Investigator

University of Iowa

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported